Australian veterinarians can now purchase our full range of products directly from Zoetis.
Zoetis Direct is a business-to-business initiative. Zoetis does not supply products directly to the general public.
VIDEO: OVERVIEW OF ZOETIS DIRECT
Zoetis Direct evolves the way we deliver value to you, your clinic and importantly to your patients. You will enjoy transparent pricing, a simple ordering system, seamless delivery and easy access to expert advice through our direct distribution commitment.
RespiSure® is a bacterin vaccine for vaccination of healthy pigs as an aid in the prevention of chronic pneumonia caused by Mycoplasma hyopneumoniae for a period of 22 weeks after vaccination. RespiSure® contains chemically inactivated whole cell culture of M. hyopneumoniae, coupled with the unique oil adjuvant Amphigen, to enhance and prolong the immune response without causing detectable tissue damage at the injection site.
RespiSure® helps protect against Enzootic pneumonia caused by M. hyopneumoniae. Preventing mycoplasmal pneumonia is often the best way to keep pigs from hitting the "Porcine Respiratory Disease wall." Controlling chronic pneumonia by vaccination saves on costly treatment and increases your profit potential. The economic impact of mycoplasmal pneumonia goes beyond initial infection. Acting as a primary pathogen, M. hyopneumoniae opens the door for secondary infections that can lead to further serious respiratory diseases. M. hyopneumoniae damages the lungs and weakens the pig's natural barrier to infection. With this primary defense system damaged, other bacterial and viral pathogens can invade the lungs.